Opendata, web and dolomites

HemoScreen SIGNED

Point-of-care hematology analyser based on visco-elastic focusing, digital imaging, image processing and machine learning

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 HemoScreen project word cloud

Explore the words cloud of the HemoScreen project. It provides you a very rough idea of what is the project "HemoScreen" about.

containing    families    certification    industrialization    device    segments    physicians    true    series    hematology    min    microfluidic    imaging    cutting    patented    safety    instead    inefficiencies    outcomes    gold    sites    sweden    belgium    external    usa    spread    clia    transcription    24    waiver    hours    uses    poc    2020    full    efficient    direct    pixcell    operated    patient    time    2022    office    85    500    portable    tests    trial    treatment    performance    diagnostics    classification    uk    accordance    point    first    errors    physician    characterization    patent    introduction    ultimately    hemoscreen    care    50    oncology    thousands    cell    calibration    standard    run    revenues    blood    glucose    market    reducing    lab    waiting    cartridges    forecasts    vision    disposable    affordable    filed    analyser    fda    employees    maintenance    reduce    headcount    requiring    launch    minimizing    relies    flow    cytometry    revolutionize    medical    72    feedback    improvement    8kg    visco    designed    elastic    labs    preliminary    hydrodynamic    neonatal    purchasing    chip    pol    36m    least    conduct    trials   

Project "HemoScreen" data sheet

The following table provides information about the project.

Coordinator
PIXCELL MEDICAL TECHNOLOGIES LTD 

Organization address
address: 6 HAYEZIRA ST
city: YOKNEAM ILIT
postcode: 2069202
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Total cost 3˙556˙337 €
 EC max contribution 2˙489˙436 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2018
 Duration (year-month-day) from 2018-06-01   to  2020-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    PIXCELL MEDICAL TECHNOLOGIES LTD IL (YOKNEAM ILIT) coordinator 2˙489˙436.00

Map

 Project objective

HemoScreen is the first true point-of-care hematology analyser: a portable (8kg) and affordable (€4,500) device that can be operated by any medical personnel (no maintenance or calibration). The analyser uses low-cost (€8) disposable cartridges containing a high performance microfluidic chip. The phase 1 market study identified three priority segments for market introduction: physician office labs (POL), oncology and neonatal. In all 3 segments, HemoScreen can reduce the cost of the blood test by at least 50% as physicians can run the test with their own equipment instead of purchasing it from an external lab. More importantly, physicians can get immediate (9 min) results instead of waiting for 24-72 hours, cutting operational inefficiencies, reducing medical transcription errors, improving patient safety, minimizing the time to adequate treatment and ultimately, improving patient outcomes. HemoScreen relies on direct cell characterization based on imaging, the gold standard for cell classification, and a patented visco-elastic focusing method, which is more robust and efficient than hydrodynamic focusing (used in flow cytometry). The technology has already generated 7 patent families and 3 more are expected to be filed during this project. The project will conduct a series of trials involving over 4,000 blood tests over 5 trial sites spread between Sweden, Belgium, UK and USA. The trial results will be used for product improvement, industrialization and certification. Based on preliminary feedback from the FDA, the HemoScreen is the first true hematology POC analyser designed in accordance with CLIA waiver requirements, enabling thousands of physicians to run their own blood tests without requiring any lab certification. PixCell’s vision is to make cell-based diagnostics as simple as a glucose test and revolutionize POC diagnostics. Following a full market launch in 2020, PixCell medical forecasts revenues of €36M and headcount of 85 employees by 2022.

 Deliverables

List of deliverables.
Project website Websites, patent fillings, videos etc. 2020-01-16 15:53:22

Take a look to the deliverables list in detail:  detailed list of HemoScreen deliverables.

 Publications

year authors and title journal last update
List of publications.
2019 Anders Larsson
Hämatologi, ett laboratorieområde som kanske står inför stora förändringar
published pages: , ISSN: 1101-2013, DOI:
Nordisk Forening for Klinisk Kemi 2020-01-16
2019 Anders Larsson, Lena Carlsson, Bo Karlsson, Miklos Lipcsey
Rapid testing of red blood cell parameters in primary care patients using HemoScreenâ„¢ point of care instrument
published pages: , ISSN: 1471-2296, DOI: 10.1186/s12875-019-0971-2
BMC Family Practice 20/1 2020-01-16
2018 Anders Larsson, David Smekal, Miklos Lipcsey
Rapid testing of red blood cells, white blood cells and platelets in intensive care patients using the HemoScreenâ„¢ point-of-care analyzer
published pages: 1-4, ISSN: 0953-7104, DOI: 10.1080/09537104.2018.1557619
Platelets 2020-01-16
2018 Miklos Lipcsey, Johanna Helmersson-Karlqvist, Anders Larsson
Point of Care Testing of Red Blood Cells and Platelets in Intensive Care Patients Using HemoScreen
published pages: , ISSN: , DOI:
2020-01-16
2018 Miklos Lipcsey, Johanna Helmersson-Karlqvist, Anders Larsson
Rapid testing of red blood cells and platelets in intensive care patients using HemoScreenâ„¢ point of care instrument
published pages: , ISSN: , DOI:
2020-01-16

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HEMOSCREEN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HEMOSCREEN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DNA DS (2019)

DNA Data storage

Read More  

ERGOVIAkinematix (2018)

New wearable measurement devices for Industry 4.0 based on gaming motion-capture system

Read More  

LiCrete (2018)

LiCrete - Light transmitting composite material for building purposes

Read More